Edwards Lifesciences and JenaValve said they remain committed to completing the deal and would defend the case in court.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for ...

BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

The bloc has now paused implementation three times, with the latest moratorium coming after reaching a framework deal with ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing ...

More than 60 companies, including Amazon, Google, UnitedHealth and Epic, have pledged to participate in the initiative, which ...

Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.